Abstract: A composition including an amphiphilic compound capable of self-assembling into liquid crystalline particles and a statin for systemic administration via oral mucosa. A method of lowering blood cholesterol levels in a subject comprising administering the self-assembling liquid crystalline particles and statin via oral mucosa. Preferred dosage forms result in prolonged release of the statin.

Abstract: An oral disintegrating tablet that forms liquid crystalline particles or liquid crystalline bulk phase upon disintegration. The oral disintegrating tablet is fast disintegrating following contact with saliva and/or the oral mucosa but also provides slowed delivery of the active ingredient to avoid the difficulties associated with the speed of delivery of an active ingredient through the oral mucosa.

Abstract: A composition including an amphiphilic compound capable of self-assembling into liquid crystalline particles and a statin for systemic administration via oral mucosa. A method of lowering blood cholesterol levels in a subject comprising administering the self-assembling liquid crystalline particles and statin via oral mucosa. Preferred dosage forms result in prolonged release of the statin.

Abstract: A composition including an amphiphilic compound capable of self-assembling into liquid crystalline particles and a statin for systemic administration via oral mucosa. A method of lowering blood cholesterol levels in a subject comprising administering the self-assembling liquid crystalline particles and statin via oral mucosa. Preferred dosage forms result in prolonged release of the statin.

Abstract: An oral disintegrating tablet that forms liquid crystalline particles or liquid crystalline bulk phase upon disintegration. The oral disintegrating tablet is fast disintegrating following contact with saliva and/or the oral mucosa but also provides slowed delivery of the active ingredient to avoid the difficulties associated with the speed of delivery of an active ingredient through the oral mucosa.

Abstract: A composition including an amphiphilic compound capable of self-assembling into liquid crystalline particles and a statin for systemic administration via oral mucosa. A method of lowering blood cholesterol levels in a subject comprising administering the self-assembling liquid crystalline particles and statin via oral mucosa. Preferred dosage forms result in prolonged release of the statin.

Abstract: A scalable architecture to solve assortment problems. Relevant data is loaded into various data stores throughout the architecture. A user specifies the problem using an interactive user interface. A dispatcher process takes the problem and delegates it to individual data stores. The data stores solve their delegated problems and return the results to the dispatcher, which aggregates the results and presents them to the user as an optimal solution to the assortment problem.

Abstract: A scalable architecture to solve assortment problems. Relevant data is loaded into various data stores throughout the architecture. A user specifies the problem using an interactive user interface. A dispatcher process takes the problem and delegates it to individual data stores. The data stores solve their delegated problems and return the results to the dispatcher, which aggregates the results and presents them to the user as an optimal solution to the assortment problem.

Abstract: A scalable architecture to solve assortment problems. Relevant data is loaded into various data stores throughout the architecture. A user specifies the problem using an interactive user interface. A dispatcher process takes the problem and delegates it to individual data stores. The data stores solve their delegated problems and return the results to the dispatcher, which aggregates the results and presents them to the user as an optimal solution to the assortment problem.

Abstract: The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound. In another aspect, the present invention provides a method for the treatment of a disease state comprising administering a therapeutically effective amount of a pharmaceutical composition incorporating that composition.

Abstract: The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound.

Abstract: The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound. In another aspect, the present invention provides a method for the treatment of a disease state comprising administering a therapeutically effective amount of a pharmaceutical composition incorporating that composition.

Abstract: A scalable architecture to solve assortment problems. Relevant data is loaded into various data stores throughout the architecture. A user specifies the problem using an interactive user interface. A dispatcher process takes the problem and delegates it to individual data stores. The data stores solve their delegated problems and return the results to the dispatcher, which aggregates the results and presents them to the user as an optimal solution to the assortment problem.

Abstract: The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound.

Abstract: The present invention relates to a process for producing an extract derived from sugar cane, the process comprising: i) mixing a sugar cane derived product with ethanol to produce an extraction mixture comprising at least about 50% v/v ethanol; ii) allowing a precipitate to form in the extraction mixture; iii) removing the precipitate from the extraction mixture to obtain a supernatant; and iv) removing ethanol from the supernatant to produce the extract derived from sugar cane. The present invention further relates to extracts produced according to the process of the invention. The invention also relates to the use of such extracts in a method of lowering the available calorific value of a food or beverage, in treating or preventing disease, and as a nutritional supplement, dietary supplement, sports nutrition product, food coating or pharmaceutical product.

Abstract: This invention adds new markings to an original check face prior to tender and processing of the check. These markings, when digitally scanned from the original, are readily interpreted and preserved. During the process of truncating the original with image replacement documents (IRDs) that are the legal equivalent, the new markings solve two major problems when the IRDs are formally introduced into the clearinghouse channel. First, the clipped image of the original check can be properly aligned within a designated region within the IRD based on the uniform markings. Second, data content aligned in reference to the uniform markings preserved in the IRD process can be properly recognized and read as if the software was scanning the original physical document.

Abstract: Presented is a system and method for determining a total cost of a foreign originating product in a customer's local currency. The system allows a customer to shop via electronic methods regardless of a merchant's location country and receive the total final cost of the product in the customer's local currency. Currency exchange, duties and tariffs, taxes and shipping are included in the given total cost of the product. The system also includes a duty estimation system for estimating duty charges prior to a product crossing an international border is disclosed. The product is categorized according to product categories set by each country.